As of 2023, the UK imported 2.69 million kilograms of antisera and other blood fractions. Forecasts suggest a declining trend from 2024 through 2028, with imports decreasing from 2.5279 million kilograms in 2024 to 2.0781 million kilograms in 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) displays a continuous decline, averaging a decrease in volume each year.

Future trends to watch for:

Changes in domestic demand and production capabilities impacting import needs.
Potential shifts in global trade policies or regulations affecting the supply chain.
Advancements in medical technologies possibly reducing demand for imported blood fractions.